Search




Results 1-10 of 19.
 |   | 
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC660542012Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer modelGUSTAFSSON Anna; BAECK Tom; ELGQVIST Joergen; JACOBSSON Lars; HULTBORN Ragnar; ALBERTSSON Per; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; JENSEN Holger; LINDEGREN Sture
JRC655342012Treatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent miceJIANG Z.; BRYAN R. A.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; Casadevall Arturo; DADACHOVA E.
JRC709082012Measurement of the 225Ac half-lifePOMME Stefaan; MAROULI MARIA; SULIMAN GABRIEL; DIKMEN HASAN; VAN AMMEL Raf; JOBBAGY VIKTOR; DIRICAN A.; STROH HEIKO; PAEPEN Jan; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; MORGENSTERN Alfred
JRC680422012Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosisESSLER M.; GAERTNER F. C.; NEFF Frauke; BLECHERT B.; SENEKOWITSCH-SCHMIDTKE R.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SEIDL C.
JRC658872012Polymersomes as nano-carriers to retain harmful recoil nuclides in alpha radionuclide therapy: a feasibility studyTHIJSEN L.; SCHAART D.r.; DE VRIES D.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DENKOVA A.g.
JRC704872012Feasibility of 99Mo production by proton-induced fission of 232ThABBAS Kamel; HOLZWARTH Uwe; SIMONELLI Federica; KOZEMPEL JAN; CYDZIK Izabela; BULGHERONI A.; COTOGNO Giulio; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; MORGENSTERN Alfred
JRC648812012High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneumRAUCH C; SEIDL C.; SCHLAPSCHY M; SKERRA A; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SENEKOWITSCH-SCHMIDTKE R.
JRC702962012Radiopeptidtherapie des Ovarialkarzinoms mit Alphastrahlern: Verbesserte Tumorkontrolle durch Kombination von 213Bi-DTPA-F3 mit Taxol bei irreversiblen Zellzyklusarrest von Ovarialkarzinomzellen in der G2/M-PhaseSEIDL C.; VALLON M.; BLECHERT B.; GÄRTNER Florian; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.
JRC702982012Die intravesikale Radioimmuntherapie mit Bi-213-anti-EGFR Immunkonjugaten verursacht keine Schäden am UrothelMÜLLER Felix; SEIDL C.; WEIRICH G; RÖTZER S; FAZEL J; FRANK Annette; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SENEKOWITSCH-SCHMIDTKE R.
JRC702992012In vitro evaluation of alpha-particle emitter Ac-225 for somatostatin receptor radiotherapyGRAF Franziska; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; VENKATACHALAM S.; FOTTNER C.; WEBER M.m.; KAINA B; SCHRECKENBERGER M; MIEDERER Matthias